Massachusetts Financial Services’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $4.15M | Buy |
|
|||||
|
2023
Q1 | $6.79M | Sell |
|
|||||
|
2022
Q4 | $9.78M | Buy |
|
|||||
|
2022
Q3 | $5.37M | Buy |
|
|||||
|
2022
Q2 | $5.58M | Sell |
|
|||||
|
2022
Q1 | $8.91M | Buy |
|
|||||
|
2021
Q4 | $8.43M | Sell |
|
|||||
|
2021
Q3 | $12.7M | Buy |
|
|||||
|
2021
Q2 | $8.36M | Sell |
|
|||||
|
2021
Q1 | $12.5M | Sell |
|
|||||
|
2020
Q4 | $13.7M | Buy |
|
|||||
|
2020
Q3 | $12.6M | Sell |
|
|||||
|
2020
Q2 | $15.8M | Buy |
|
|||||
|
2020
Q1 | $6.13M | Buy |
|